期刊
FREE RADICAL BIOLOGY AND MEDICINE
卷 169, 期 -, 页码 258-270出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2021.04.023
关键词
Hypoxia; Anoxia; Kidney; Oxidative stress; NO; ROS
资金
- Societe de Reanimation de Langue Francaise (SRLF)
- Agence Nationale pour la Recherche (ANR)
Disorders characterized by ischemia/reperfusion (I/R) are the most common causes of debilitating diseases and death in stroke, cardiovascular ischemia, acute kidney injury or organ transplantation. During transplantation, the I/R step defines both the amplitude of the damages to the graft and the functional recovery outcome. Oxidative stress plays a crucial role in cell death and tissue damage, and finding treatments to reduce or prevent oxidative stress in ischemic pathologies is a key goal for better outcomes in organ transplantation.
Disorders characterized by ischemia/reperfusion (I/R) are the most common causes of debilitating diseases and death in stroke, cardiovascular ischemia, acute kidney injury or organ transplantation. In the latter example the I/R step defines both the amplitude of the damages to the graft and the functional recovery outcome. During transplantation the kidney is subjected to blood flow arrest followed by a sudden increase in oxygen supply at the time of reperfusion. This essential clinical protocol causes massive oxidative stress which is at the basis of cell death and tissue damage. The involvement of both reactive oxygen species (ROS) and nitric oxides (NO) has been shown to be a major cause of these cellular damages. In fact, in non-physiological situations, these species escape endogenous antioxidant control and dangerously accumulate in cells. In recent years, the objective has been to find clinical and pharmacological treatments to reduce or prevent the appearance of oxidative stress in ischemic pathologies. This is very relevant because, due to the increasing success of organ transplantation, clinicians are required to use limit organs, the preservation of which against oxidative stress is crucial for a better outcome. This review highlights the key actors in oxidative stress which could represent new pharmacological targets.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据